1. Home
  2. People
  3. Savage, Andrew

Andrew Savage

Managing Associate

Boston

Andrew focuses on representing high growth technology, life sciences and energy companies at every stage of their business life cycle.

He advises on a broad range of transactional and corporate matters, starting with initial formation and through to exits, including incorporation, governance matters, venture financings and M&A transactions. Andrew also advises venture capital and private equity firms among other strategic investors.

    • Mews Systems in its Series D financing ($300M)*
    • Crosspoint Capital Partners in its Series B investment in TENEX.AI ($250M)*
    • Atavistik Bio in its Series B financings ($160M)*
    • Glycomine in its Series C financing ($115M)*
    • ThayerMahan in its Series C financings ($50M)*
    • IonQ in various equity investments and public company representation*
    • 4me in its strategic growth investment from PSG Equity*
    • Fastcase in its merger with vLex*
    • DispatchHealth in its merger with Medically Home Group*
    • Roche Bros. in its sale of a controlling interest*
    • Represented multiple energy innovation companies in public-private partnerships and joint ventures including those involving DOE grants*
    • Represented nuclear fuel innovation company in first of kind agreement with DOE*

    *Includes matters handled prior to joining Orrick